Mental health and COVID-19 in a general population cohort in Spain (COVICAT study).
Anxiety
COVID-19
Cohort study
Depression
Lockdown
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
16
12
2021
accepted:
05
05
2022
pubmed:
29
5
2022
medline:
22
11
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Mental health conditions may affect outcome of COVID-19 disease, while exposure to stressors during the pandemic may impact mental health. The purpose of this study was to examine these factors in relation to ocurrence of depression and anxiety after the first outbreak in Spain. We contacted 9515 participants from a population-based cohort study in Catalonia between May and October 2020. We drew blood samples to establish infection to the virus. Pre-pandemic mental health conditions were confirmed through Electronic Health Registries. We used the Hospital Anxiety and Depression Scale to assess severe depression and anxiety post-pandemic. Exposure to proximal, financial and wider environment stressors during the lockdown were collected. We calculated Relative Risks (RR), adjusting for individual- and contextual covariates. Pre-pandemic mental health disorders were not associated with SARS-CoV-2 infection , but were associated with severity of COVID-19 disease. People with pre-existing mental health disorders showed higher prevalence of severe depression (25.4%) and anxiety (37.8%) than those without prior mental disorders (4.9% and 10.1%). Living alone was a strong predictor of severe depression among mental health patients (RR = 1.6, 95% CI 1.2-2.2). Among those without prior mental health disorders, post-lockdown depression and anxiety were associated with household interpersonal conflicts (RR = 2.6, 95% CI 2.1-3.1; RR = 2.1, 95% CI 1.9-2.4) and financial instability (RR = 2.2, 95% CI 1.8-2.9; 1.9, 95% CI 1.6-2.2). The COVID-19 pandemic and the lockdown were associated with increased post-lockdown depression and anxiety. Patients with pre-existing mental health conditions are a vulnerable group for severe COVID-19 disease.
Identifiants
pubmed: 35633398
doi: 10.1007/s00127-022-02303-0
pii: 10.1007/s00127-022-02303-0
pmc: PMC9142833
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2457-2468Subventions
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : CEX2018-000806-S
Organisme : Generalitat de Catalunya
ID : ADE 10/00026
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : 2017-SGR 529
Organisme : Instituto de Salud Carlos III
ID : PI17/01555
Informations de copyright
© 2022. The Author(s).
Références
Psychiatry Res. 2021 Aug;302:114045
pubmed: 34126461
Front Immunol. 2022 Feb 04;13:798538
pubmed: 35185890
Am J Epidemiol. 2015 Sep 15;182(6):544-56
pubmed: 26306665
Soc Psychiatry Psychiatr Epidemiol. 2021 Jan;56(1):13-24
pubmed: 32804258
Lancet. 2006 Oct 7;368(9543):1260-9
pubmed: 17027732
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
Lancet Psychiatry. 2021 Feb;8(2):141-149
pubmed: 33308420
BMJ Glob Health. 2020 Jan 26;5(1):e002208
pubmed: 32133178
J Clin Med. 2020 Nov 23;9(11):
pubmed: 33238610
BMJ Open. 2018 Mar 27;8(3):e018324
pubmed: 29593016
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
Lancet Psychiatry. 2017 Feb;4(2):146-158
pubmed: 27856392
PLoS One. 2022 Mar 1;17(3):e0264325
pubmed: 35231037
Hum Mol Genet. 2022 Jul 15;:
pubmed: 35848942
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Environ Health Perspect. 2016 May;124(5):578-85
pubmed: 26606640
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
BJPsych Open. 2021 Oct 01;7(6):e183
pubmed: 34659793
Nat Rev Dis Primers. 2017 May 04;3:17024
pubmed: 28470168
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Lancet. 2018 Feb 3;391(10119):426
pubmed: 29407030
Annu Rev Public Health. 2013;34:119-38
pubmed: 23514317
Transl Psychiatry. 2021 Mar 15;11(1):160
pubmed: 33723208
Psychiatry Res. 2021 Mar;297:113714
pubmed: 33453497
Lancet Psychiatry. 2020 Dec;7(12):1025-1031
pubmed: 32950066
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Int Rev Psychiatry. 2014 Aug;26(4):392-407
pubmed: 25137105
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33127841
Nature. 2021 Dec;600(7889):472-477
pubmed: 34237774
Eur J Epidemiol. 2020 Nov;35(11):1007-1019
pubmed: 32959148
EClinicalMedicine. 2021 Oct;40:101111
pubmed: 34514362
Psychol Rev. 1994 Oct;101(4):568-86
pubmed: 7984707
Depress Anxiety. 2020 Oct;37(10):957-964
pubmed: 32667117
Psychol Med. 2020 Dec 07;:1-10
pubmed: 33280639
JAMA. 2020 Oct 20;324(15):1493-1494
pubmed: 33044510
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Sci Adv. 2019 Jul 24;5(7):eaax0903
pubmed: 31355340
BMC Public Health. 2017 Apr 12;17(1):315
pubmed: 28403870
Sci Rep. 2021 Nov 3;11(1):21571
pubmed: 34732749
Soc Psychiatry Psychiatr Epidemiol. 2022 Jun;57(6):1261-1272
pubmed: 34766187
JAMA Netw Open. 2021 Feb 1;4(2):e2037665
pubmed: 33606030
Front Psychiatry. 2020 Dec 16;11:581426
pubmed: 33391049
J Epidemiol Community Health. 2021 Sep;75(9):817-823
pubmed: 33483341